Search Results - "Cromer, J"

Algorithmic identification of atypical diabetes in electronic health record (EHR) systems by Cromer, Sara J, Chen, Victoria, Han, Christopher, Marshall, William, Emongo, Shekina, Greaux, Evelyn, Majarian, Tim, Florez, Jose C, Mercader, Josep, Udler, Miriam S

“…Understanding atypical forms of diabetes (AD) may advance precision medicine, but methods to identify such patients are needed. We propose an electronic health…”
Get full text

Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19 by Schroeder, Philip H, Brenner, Laura N, Kaur, Varinderpal, Cromer, Sara J, Armstrong, Katrina, LaRocque, Regina C, Ryan, Edward T, Meigs, James B, Florez, Jose C, Charles, Richelle C, Mercader, Josep M, Leong, Aaron

“…The high heterogeneity in the symptoms and severity of COVID-19 makes it challenging to identify high-risk patients early in the disease. Cardiometabolic…”
Get full text

Outcomes of Negative Pressure Wound Therapy on Immediate Breast Reconstruction after Mastectomy by Akhter, Haris M, Macdonald, Collin, McCarthy, Philip, Huang, Ye, Meyer, Bria R, Shostrum, Valerie K, Cromer, Kerry J, Johnson, Perry J, Wong, Shannon L, Hon, Heidi H

“…Immediate expander/implant-based breast reconstruction after mastectomy has become more sought after by patients. Although many patients choose this technique…”
Get full text

Enrollment of underrepresented racial and ethnic groups in the Rare and Atypical Diabetes Network (RADIANT) by Tosur, Mustafa, Gandolfo, Laura, Balasubramanyam, Ashok, Naylor, Rochelle N, Pollin, Toni I, Rasouli, Neda, Cromer, Sara J, Buse, John B, Redondo, Maria J

“…Diabetes mellitus in underrepresented racial and ethnic groups (URG) is rapidly increasing in incidence and has worse outcomes than diabetes in non-Hispanic…”
Get full text

GLP-1 Receptor Agonists and Gastrointestinal Adverse Events by Suissa, Karine, Cromer, Sara J, Patorno, Elisabetta

Get full text

Does the effect of lifestyle intervention for individuals with diabetes vary by food insecurity status? A preplanned subgroup analysis of the REAL HEALTH randomized clinical trial by Berkowitz, Seth A, Chang, Yuchiao, Porneala, Bianca, Cromer, Sara J, Wexler, Deborah J, Delahanty, Linda M

“…IntroductionWe aimed to test the effectiveness of a lifestyle intervention (LI) for individuals with food insecurity and type 2 diabetes.Research design and…”
Get full text

The Keck Low-Resolution Imaging Spectrometer by Oke, J. B., Cohen, J. G., Carr, M., Cromer, J., Dingizian, A., Harris, F. H., Labrecque, S., Lucinio, R., Schaal, W., Epps, H., Miller, J.

“…The Low Resolution Imaging Spectrometer (LRIS) for the Cassegrain focus of the Keck 10-m telescope on Mauna Kea is described. It has an imaging mode so it can…”
Get full text

Deficits and Disparities in Early Uptake of Glucagon-Like Peptide 1 Receptor Agonists and SGLT2i Among Medicare-Insured Adults Following a New Diagnosis of Cardiovascular Disease or Heart Failure by Cromer, Sara J, Lauffenburger, Julie C, Levin, Raisa, Patorno, Elisabetta

“…To examine the association of race/ethnicity and socioeconomic deprivation with initiation of guideline-recommended diabetes medications with cardiovascular…”
Get full text

Total therapy with tandem transplants for newly diagnosed multiple myeloma by BARLOGIE, B, JAGANNATH, S, MEHTA, J, ANAISSIE, E, DHODAPKAR, D, NAUCKE, S, CROMER, J, SAWYER, J, EPSTEIN, J, SPOON, D, AYERS, D, CHESON, B, DESIKAN, K. R, CROWLEY, J, MATTOX, S, VESOLE, D, SIEGEL, D, TRICOT, G, MUNSHI, N, FASSAS, A, SINGHAL, S

“…Between August 1990 and August 1995, 231 patients (median age 51, 53% Durie-Salmon stage III, median serum beta-2-microglobulin 3.1 g/L, median C-reactive…”
Get full text

Challenges and Opportunities for Osteoporosis Care During the COVID-19 Pandemic by Cromer, Sara J, Yu, Elaine W

“…The coronavirus disease 2019 (COVID-19) has both directly and indirectly affected osteoporosis diagnosis and treatment throughout the world. This mini-review…”
Get full text

Racial/ethnic and socioeconomic disparities in achievement of treatment goals within a clinical trial: a secondary analysis of the ACCORD trial by Cromer, Sara J., Thaweethai, Tanayott, Wexler, Deborah J.

“…Aims/hypothesis Clinical trial participation should theoretically reduce barriers to care by ensuring medication and healthcare access. We aimed to evaluate…”
Get full text

Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma by Barlogie, B., Jagannath, S., Desikan, K.R., Mattox, S., Vesole, D., Siegel, D., Tricot, G., Munshi, N., Fassas, A., Singhal, S., Mehta, J., Anaissie, E., Dhodapkar, D., Naucke, S., Cromer, J., Sawyer, J., Epstein, J., Spoon, D., Ayers, D., Cheson, B., Crowley, J.

“…Between August 1990 and August 1995, 231 patients (median age 51, 53% Durie-Salmon stage III, median serum β-2-microglobulin 3.1 g/L, median C-reactive protein…”
Get full text

Cross-cultural adaptation of a research version of the rey auditory verbal learning test (RAVLT) into japanese by Cromer, J, Krishna, V, Nguyen, A, Acquadro, C, Fuller, D.S

Get full text

Clinical utility of serum amyloid A and macrophage migration inhibitory factor as serum biomarkers for the detection of nonsmall cell lung carcinoma by Khan, Nayela, Cromer, Charles J., Campa, Michael, Patz, Edward F.

“…BACKGROUND Early lung carcinoma detection strategies involving imaging studies have yet to demonstrate a reduction in mortality. Identification of serum…”
Get full text

SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study by Fu, Edouard L, Wexler, Deborah J, Cromer, Sara J, Bykov, Katsiaryna, Paik, Julie M, Patorno, Elisabetta

“…To evaluate the comparative effectiveness of sodium-glucose cotransporter-2 (SGLT-2) inhibitors, glucagon-like peptide-1 (GLP-1) receptor agonists, and…”
Get more information

Barriers to Healthcare Access Facing American Indian and Alaska Natives in Rural America by Cromer, Kerry J., Wofford, Linda, Wyant, David K.

“…We provide a literature review concerning healthcare access for Native Americans in rural areas. We group previous research around three themes; barriers in…”
Get full text

Racial/ethnic and socioeconomic disparities in weight outcomes, cardiovascular events, and mortality in the look AHEAD trial by Cromer, Sara J., Meigs, James, Wexler, Deborah J.

“…Intensive lifestyle interventions (ILI) for type 2 diabetes (T2D) improve health outcomes, but participants from different races/ethnicities or socioeconomic…”
Get full text

Comparing Insulin Against Glucagon-Like Peptide-1 Receptor Agonists, Dipeptidyl Peptidase-4 Inhibitors, and Sodium-Glucose Cotransporter 2 Inhibitors on 5-Year Incident Heart Failure Risk for Patients With Type 2 Diabetes Mellitus: Real-World Evidence Study Using Insurance Claims by Wang, Xuan, Plantinga, Anna M, Xiong, Xin, Cromer, Sara J, Bonzel, Clara-Lea, Panickan, Vidul, Duan, Rui, Hou, Jue, Cai, Tianxi

“…Type 2 diabetes mellitus (T2DM) is a common health issue, with heart failure (HF) being a common and lethal long-term complication. Although insulin is widely…”
Get full text

Newly diagnosed diabetes vs. pre-existing diabetes upon admission for COVID-19: Associated factors, short-term outcomes, and long-term glycemic phenotypes by Cromer, Sara J., Colling, Caitlin, Schatoff, Daria, Leary, Michael, Stamou, Maria I., Selen, Daryl J., Putman, Melissa S., Wexler, Deborah J.

“…High rates of newly diagnosed diabetes mellitus (NDDM) have been reported in association with coronavirus disease-2019 (COVID-19). Factors associated with NDDM…”
Get full text

Precision subclassification of type 2 diabetes: a systematic review by Misra, Shivani, Wagner, Robert, Ozkan, Bige, Schön, Martin, Sevilla-Gonzalez, Magdalena, Prystupa, Katsiaryna, Wang, Caroline C., Kreienkamp, Raymond J., Cromer, Sara J., Rooney, Mary R., Duan, Daisy, Thuesen, Anne Cathrine Baun, Wallace, Amelia S., Leong, Aaron, Deutsch, Aaron J., Andersen, Mette K., Billings, Liana K., Eckel, Robert H., Sheu, Wayne Huey-Herng, Hansen, Torben, Stefan, Norbert, Goodarzi, Mark O., Ray, Debashree, Selvin, Elizabeth, Florez, Jose C., Meigs, James B., Udler, Miriam S.

“…Background Heterogeneity in type 2 diabetes presentation and progression suggests that precision medicine interventions could improve clinical outcomes. We…”
Get full text